These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 21675043

  • 1. Portal-systemic shunt between the inferior mesenteric vein and inferior vena cava in a patient with hepatic encephalopathy: successful occlusion by balloon-occluded retrograde transvenous obliteration.
    Kakizawa H, Toyota N, Hieda M, Ishikawa M, Tanitame K, Tani C, Okazaki A, Takaki S, Aikata H, Chayama K, Awai K.
    Hiroshima J Med Sci; 2011 Mar; 60(1):15-9. PubMed ID: 21675043
    [Abstract] [Full Text] [Related]

  • 2. Balloon-occluded retrograde transvenous obliteration (BRTO) for a direct shunt between the inferior mesenteric vein and the inferior vena cava in a patient with hepatic encephalopathy.
    Ibukuro K, Sugihara T, Tanaka R, Fukuda H, Abe S, Tobe K, Tateishi R, Tagawa K.
    J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):121-5. PubMed ID: 17296712
    [Abstract] [Full Text] [Related]

  • 3. Treatment of hepatic encephalopathy due to inferior mesenteric vein/inferior vena cava and gonadal vein shunt using dual balloon-occluded retrograde transvenous obliteration.
    Tanaka R, Ibukuro K, Abe S, Tobe K, Fukuda H, Kondou Y, Tagawa K.
    Cardiovasc Intervent Radiol; 2009 Mar; 32(2):390-3. PubMed ID: 18839245
    [No Abstract] [Full Text] [Related]

  • 4. Successful portal-systemic shunt occlusion of a direct shunt between the inferior mesenteric vein and inferior vena cava with balloon-occluded retrograde transvenous obliteration following recanalization after placing a covered stent in the portal and superior mesenteric veins.
    Hayashi S, Baba Y, Senokuchi T, Ueno K, Nakajo M.
    Jpn J Radiol; 2009 May; 27(4):180-4. PubMed ID: 19499309
    [Abstract] [Full Text] [Related]

  • 5. Effective balloon-occluded retrograde transvenous obliteration of the superior mesenteric vein-inferior vena cava shunt in a patient with hepatic encephalopathy after living donor liver transplantation.
    Baimakhanov Z, Soyama A, Takatsuki M, Inoue Y, Matsushima H, Hidaka M, Kitasato A, Adachi T, Kuroki T, Sakomoto I, Eguchi S.
    Clin J Gastroenterol; 2014 Aug; 7(4):342-5. PubMed ID: 26185885
    [Abstract] [Full Text] [Related]

  • 6. [A case of portal-systemic shunt-through inferior mesenteric vein and right internal iliac vein-encephalopathy cured by balloon-occluded retrograde transvenous obliteration].
    Shimizu K, Nakashima M, Fujimoto M, Tsuruta S, Morita S, Furukawa R, Mori M.
    Nihon Shokakibyo Gakkai Zasshi; 2009 Dec; 106(12):1764-9. PubMed ID: 19966519
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of balloon-occluded retrograde transvenous obliteration (B-RTO) performed in a patient with primary biliary cirrhosis with severe recurrent hepatic encephalopathy due to splenorenal shunt.
    Takashimizu S, Watanabe N, Kojima S, Kagawa T, Mine T, Myojin K, Koizumi J.
    Tokai J Exp Clin Med; 2007 Jul 20; 32(2):70-4. PubMed ID: 21319062
    [Abstract] [Full Text] [Related]

  • 8. [Successful balloon-occluded retrograde transvenous obliteration (B-RTO) in a case of symptomatic epilepsy with hepatic encephalopathy due to non-cirrhotic porto-systemic shunt].
    Shibata A, Hayashi S, Noguchi M.
    Rinsho Shinkeigaku; 2005 May 20; 45(5):341-5. PubMed ID: 15960169
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Disabling portosystemic encephalopathy in a non-cirrhotic patient: Successful endovascular treatment of a giant inferior mesenteric-caval shunt via the left internal iliac vein.
    de Martinis L, Groppelli G, Corti R, Moramarco LP, Quaretti P, De Cata P, Rotondi M, Chiovato L.
    World J Gastroenterol; 2017 Dec 21; 23(47):8426-8431. PubMed ID: 29308002
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A case of adult onset type II citrullinemia with portal-systemic shunt.
    Noto D, Takahashi K, Hamaguchi T, Inamura K, Nobata K, Yazaki M, Ikeda S, Kobayashi K, Yamada M.
    J Neurol Sci; 2009 Jun 15; 281(1-2):127-9. PubMed ID: 19285691
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intraperitoneal bleeding after balloon-occluded retrograde transvenous obliteration: a case report.
    Furue Y, Hidaka H, Fujii K, Matsunaga K, Koizumi W.
    J Med Case Rep; 2015 Mar 20; 9():62. PubMed ID: 25886049
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Extrahepatic portosystemic venous shunt without portal hypertension.
    Nishimoto Y, Hoshino H, Sato S, Oguri A, Yamada M, Nishimura D, Katada N, Sano H, Kato K.
    Intern Med; 1997 Dec 20; 36(12):886-9. PubMed ID: 9475244
    [Abstract] [Full Text] [Related]

  • 19. An unusual portal-systemic shunt, most likely through a patent ductus venosus. A case report.
    Ohnishi K, Hatano H, Nakayama T, Kohno K, Okuda K.
    Gastroenterology; 1983 Oct 20; 85(4):962-5. PubMed ID: 6884718
    [Abstract] [Full Text] [Related]

  • 20. [Intrahepatic portosystemic venous shunt via right renal vein successfully treated with balloon-occluded retrograde transvenous obliteration].
    Hashiguchi K, Yamasaki K, Ichikawa T, Takeshima F, Nakao K.
    Nihon Shokakibyo Gakkai Zasshi; 2011 Oct 20; 108(10):1726-34. PubMed ID: 21971147
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.